GE HealthCare Technologies GEHC
NASDAQ GEHC
$74.58 -0.04 (-0.05%)
At close: Aug 20, 2026 · 10:27 AM UTC

GE HealthCare Technologies (GEHC) Income from Non-Controlling Interests (2022 - 2026)

GE HealthCare Technologies' (GEHC) quarterly Income from Non-Controlling Interests came in at $13.0 million in Q2 2026, down 7.14% YoY from $14.0 million in Q2 2025, and down 40.91% on a QoQ basis from $22.0 million in Q1 2026.

GE HealthCare Technologies (GEHC) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends

GE HealthCare Technologies (GEHC) has 5 years of Income from Non-Controlling Interests data on file, last reported at $13.0 million in Q2 2026.

  • Quarterly Income from Non-Controlling Interests fell 7.14% year-over-year to $13.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $66.0 million (down 10.81% YoY) and the FY2025 annual result came in at $70.0 million, up 22.81% from the prior year.
  • Income from Non-Controlling Interests declined to $13.0 million in Q2 2026, from $22.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $24.0 million in Q1 2025 to a low of $6.0 million in Q3 2022.
  • A 5-year average of $14.3 million and a median of $13.5 million in 2022 frame the typical range for Income from Non-Controlling Interests.
  • The widest YoY moves for Income from Non-Controlling Interests: up 171.43% in 2024, down 53.33% in 2024.
  • Tracing GEHC's Income from Non-Controlling Interests over 5 years: stood at $19.0 million in 2022, then slumped by 31.58% to $13.0 million in 2023, then soared by 30.77% to $17.0 million in 2024, then decreased by 23.53% to $13.0 million in 2025, then changed by 0.0% to $13.0 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at $13.0 million (Q2 2026), $22.0 million (Q1 2026), and $13.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 199.54 Bn 193.94 Bn 7.27 Bn -
2 Stryker 129.61 Bn 126.14 Bn 4.50 Bn -
3 Medtronic 120.10 Bn 110.88 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn -2.00 Mn
5 Edwards Lifesciences 52.52 Bn 48.27 Bn 1.35 Bn -500,000.00
6 Dexcom 34.69 Bn 32.75 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.78 Bn 31.68 Bn 2.18 Bn 13.00 Mn
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 2.32 Mn
9 Steris 23.09 Bn 22.61 Bn 684.20 Mn 900,000.00
10 Zimmer Biomet Holdings 19.37 Bn 18.96 Bn 1.54 Bn 1.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 13.00 Mn
Mar 31, 2026 22.00 Mn
Dec 31, 2025 13.00 Mn
Sep 30, 2025 18.00 Mn
Jun 30, 2025 14.00 Mn
Mar 31, 2025 24.00 Mn
Dec 31, 2024 17.00 Mn
Sep 30, 2024 19.00 Mn
Jun 30, 2024 7.00 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 13.00 Mn
Sep 30, 2023 7.00 Mn
Jun 30, 2023 15.00 Mn
Mar 31, 2023 11.00 Mn
Dec 31, 2022 19.00 Mn
Sep 30, 2022 6.00 Mn
Jun 30, 2022 13.00 Mn
Mar 31, 2022 13.00 Mn